US2017196814A1PendingUtilityA1
Sustained release beads and suspensions including the same for sustained delivery of active ingredients
Assignee: NANO PHARMACEUTICAL LABORATORIES LLCPriority: Jun 26, 2009Filed: Mar 24, 2017Published: Jul 13, 2017
Est. expiryJun 26, 2029(~2.9 yrs left)· nominal 20-yr term from priority
Inventors:Robert Niichel
A61P 25/00A61P 29/00A61K 31/00A61K 33/14A23L 29/206A61K 9/50A23L 33/10A61K 33/00A23V 2002/00A23L 2/52A23L 33/16A61K 9/5047A23P 10/25A61K 9/5026A61K 9/16A23L 33/15A61K 31/522A61K 9/1652A61K 9/1635A23L 29/269
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Sustained-released beads providing active ingredients over an extended period of time to an individual orally ingesting the sustained release beads. The sustained-release beads can be part of a suspension wherein the sustained-release beads are suspended and evenly dispersed in the suspension. Binding agents are used to form the structural framework of the sustained released beads and retain the active ingredients without chemical or electrical bonding. The components of the dispersion medium are GRAS designated, making the suspension suitable for use as a food product.
Claims
exact text as granted — not AI-modifiedI/we claim:
1 . A suspension comprising:
one or more sustained sustained-release beads consisting of:
a core including one or more active ingredients and optionally water; and
at least one coating layer encapsulating the core; and
a dispersion medium comprising:
an aqueous solution; and
one or more thickening agents.
2 . The suspension of claim 1 , wherein the one or more active ingredients are non-prescription active ingredients.
3 . The suspension of claim 1 , wherein the one or more active ingredients are GRAS-designated active ingredients.
4 . The suspension of claim 1 , wherein the one or more active ingredients are selected from the group consisting of stimulants, electrolytes, vitamins, minerals, or combinations thereof.
5 . The suspension of claim 1 , wherein the one or more active ingredients are selected from the group consisting of proteins, amino acids, hormones, organic acids, or combinations thereof.
6 . The suspension of claim 1 , wherein the coating layer includes a polymer coating, a resin coating, or a lipid coating.
7 . The suspension of claim 1 , wherein each of the one or more sustained release beads comprises from 40 to 90 wt % of the one or more active ingredients and from 10 to 40 wt % of the at least one coating layer.
8 . A suspension consisting essentially of:
one or more sustained sustained-release beads having a core including one or more active ingredients and optionally water; and at least one coating layer encapsulating the core; and a dispersion medium including an aqueous solution, and one or more thickening agents.
9 . The suspension of claim 8 , wherein the one or more active ingredients are non-prescription active ingredients.
10 . The suspension of claim 8 , wherein the one or more active ingredients are GRAS-designated active ingredients.
11 . The suspension of claim 8 , wherein the one or more active ingredients are selected from the group consisting of stimulants, electrolytes, vitamins, minerals, or combinations thereof.
12 . The suspension of claim 8 , wherein the one or more active ingredients are selected from the group consisting of proteins, amino acids, hormones, organic acids, or combinations thereof.
13 . The suspension of claim 8 , wherein the coating layer includes a polymer coating, a resin coating, or a lipid coating.
14 . The suspension of claim 8 , wherein each of the one or more sustained release beads comprises from 40 to 90 wt % of the one or more active ingredients and from 10 to 40 wt % of the at least one coating layer.
15 . A suspension consisting of:
one or more sustained sustained-release bead having a core including one or more active ingredient and optionally water; and at least one coating layer encapsulating the core; and a dispersion medium including an aqueous solution, and one or more thickening agents.
16 . The suspension of claim 15 , wherein the one or more active ingredients are non-prescription active ingredients.
17 . The suspension of claim 15 , wherein the one or more active ingredients are GRAS-designated active ingredients.
18 . The suspension of claim 15 , wherein the one or more active ingredients are selected from the group consisting of stimulants, electrolytes, vitamins, minerals, or combinations thereof.
19 . The suspension of claim 15 , wherein the one or more active ingredients are selected from the group consisting of proteins, amino acids, hormones, organic acids, or combinations thereof.
20 . The suspension of claim 15 , wherein each of the one or more sustained release beads comprises from 40 to 90 wt % of the one or more active ingredients and from 10 to 40 wt % of the at least one coating layer.Join the waitlist — get patent alerts
Track US2017196814A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.